E. Bramm

1.2k total citations
38 papers, 963 citations indexed

About

E. Bramm is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, E. Bramm has authored 38 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in E. Bramm's work include Rheumatoid Arthritis Research and Therapies (5 papers), Vitamin D Research Studies (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). E. Bramm is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (5 papers), Vitamin D Research Studies (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). E. Bramm collaborates with scholars based in Denmark, Belgium and United Kingdom. E. Bramm's co-authors include Lise Binderup, E. Arrigoni‐Martelli, Scilla Latini, Piet Geusens, J. Dequeker, Michael Kragh, Torsten Skov, Sumeer Dhar, E. Jönsson and Rolf Larsson and has published in prestigious journals such as Endocrinology, Journal of Medicinal Chemistry and Journal of Bone and Mineral Research.

In The Last Decade

E. Bramm

37 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Bramm Denmark 17 326 229 219 181 115 38 963
Shigeru Tomoyasu Japan 22 718 2.2× 250 1.1× 356 1.6× 113 0.6× 94 0.8× 90 1.3k
Hervé Lemaréchal France 21 352 1.1× 260 1.1× 113 0.5× 234 1.3× 37 0.3× 33 962
Ilaria Mazzetti Italy 13 204 0.6× 55 0.2× 231 1.1× 140 0.8× 24 0.2× 17 897
J. K. Burmester United States 13 653 2.0× 228 1.0× 206 0.9× 83 0.5× 228 2.0× 25 1.3k
Catherine Cheung Australia 15 439 1.3× 102 0.4× 122 0.6× 251 1.4× 54 0.5× 30 1.1k
K W Colston United Kingdom 23 551 1.7× 1.1k 4.9× 619 2.8× 94 0.5× 685 6.0× 36 2.0k
Ewa Marcinkowska Poland 24 746 2.3× 483 2.1× 155 0.7× 184 1.0× 249 2.2× 71 1.3k
Masanobu Tsubaki Japan 31 1.2k 3.6× 152 0.7× 848 3.9× 194 1.1× 60 0.5× 93 2.2k
Juan Moreno‐Rubio Spain 19 634 1.9× 132 0.6× 288 1.3× 86 0.5× 42 0.4× 35 1.1k
Yun Liang China 15 178 0.5× 274 1.2× 135 0.6× 31 0.2× 41 0.4× 53 763

Countries citing papers authored by E. Bramm

Since Specialization
Citations

This map shows the geographic impact of E. Bramm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Bramm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Bramm more than expected).

Fields of papers citing papers by E. Bramm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Bramm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Bramm. The network helps show where E. Bramm may publish in the future.

Co-authorship network of co-authors of E. Bramm

This figure shows the co-authorship network connecting the top 25 collaborators of E. Bramm. A scholar is included among the top collaborators of E. Bramm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Bramm. E. Bramm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Latini, Scilla, Pernille Holm, Rolf Larsson, et al.. (2004). Anticancer agent CHS 828 suppresses nuclear factor‐κB activity in cancer cells through downregulation of IKK activity. International Journal of Cancer. 111(2). 198–205. 39 indexed citations
2.
Colston, K W, et al.. (2003). Effects of Seocalcitol (EB1089) on Nitrosomethyl Urea-Induced Rat Mammary Tumors. Breast Cancer Research and Treatment. 80(3). 303–311. 24 indexed citations
3.
Kragh, Michael, et al.. (2003). In vivo chamber angiogenesis assay: An optimized Matrigel plug assay for fast assessment of anti-angiogenic activity. International Journal of Oncology. 22(2). 305–11. 29 indexed citations
4.
Petersen, Hans, et al.. (1998). ChemInform Abstract: Novel Cyanoguanidines with Potent Oral Antitumor Activity.. ChemInform. 29(17). 5 indexed citations
5.
Aerssens, Jeroen, R. Van Audekercke, Marek Tałałaj, et al.. (1996). Effect of 1alpha-vitamin D3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat model.. Endocrinology. 137(4). 1358–1364. 35 indexed citations
6.
Aerssens, Jeroen, R. Van Audekercke, Marek Tałałaj, et al.. (1994). Effect of 1α-vitamin D3 on bone strength and composition in growing rats with and without corticosteroid treatment. Calcified Tissue International. 55(6). 443–450. 23 indexed citations
7.
Geusens, Piet, J. Dequeker, Jo Nijs, A Verstraeten, & E. Bramm. (1991). Prevention and treatment of osteopenia in the ovariectomized rat: Effect of combined therapy with estrogens, 1-alpha vitamin D, and prednisolone. Calcified Tissue International. 48(2). 127–137. 23 indexed citations
8.
Geusens, Piet, J. Dequeker, Jos Nijs, & E. Bramm. (1990). Effect of ovariectomy and prednisolone on bone mineral content in rats: Evaluation by single photon absorptiometry and radiogrammetry. Calcified Tissue International. 47(4). 243–250. 24 indexed citations
9.
Binderup, Lise & E. Bramm. (1988). Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochemical Pharmacology. 37(5). 889–895. 290 indexed citations
10.
Binderup, Lise, E. Bramm, & E. Arrigoni‐Martelli. (1982). Captopril (SQ 14,225): In vitro and in vivo influence on the proliferative response of rat lymphocytes. Cellular and Molecular Life Sciences. 38(3). 399–401. 7 indexed citations
11.
Binderup, Lise, E. Bramm, & E. Arrigoni‐Martelli. (1982). Antirheumatic drugs ands macrophage function: Effects on tumour cell crowth in vitro. Clinical Rheumatology. 1(1). 15–22. 2 indexed citations
12.
Bramm, E., Lise Binderup, & E. Arrigoni‐Martelli. (1981). An unusual profile of activity of a new basic anti-inflammatory drug, timegadine. Inflammation Research. 11(4). 402–409. 14 indexed citations
13.
Binderup, Lise, E. Bramm, & E. Arrigoni‐Martelli. (1980). d‐Penicillamine in Vivo Enhances Lymphocyte DN A Synthesis: Role of Macrophages. Scandinavian Journal of Immunology. 11(1). 23–28. 17 indexed citations
14.
Bramm, E., Lise Binderup, & E. Arrigoni‐Martelli. (1980). Inhibition of adjuvant arthritis by intraperitoneal administration of low doses of silica. Inflammation Research. 10(5). 435–438. 3 indexed citations
15.
Binderup, Lise, E. Bramm, & E. Arrigoni‐Martelli. (1980). Immunological Effects of d‐Penicillamine during Experimentally Induced Inflammation in Rats. Scandinavian Journal of Immunology. 12(3). 239–247. 13 indexed citations
16.
Bramm, E., Lise Binderup, & E. Arrigoni‐Martelli. (1979). Delayed Hypersensitivity to Tuberculin in Rats: Effects of Antirheumatic Drugs. Acta Pharmacologica et Toxicologica. 44(1). 75–80. 18 indexed citations
17.
Binderup, Lise, E. Bramm, & E. Arrigoni‐Martelli. (1979). Peritoneal macrophages from adjuvant arthritic rats enhance tumour cell growth in vitro. Cellular and Molecular Life Sciences. 35(9). 1230–1232. 6 indexed citations
18.
Martelli, E. Arrigoni, et al.. (1977). Effect of calcitonin on different inflammatory models. Inflammation Research. 7(5-6). 533–538. 16 indexed citations
19.
Binderup, Lise, E. Bramm, & E. Arrigoni‐Martelli. (1977). Inhibition of DNA synthesis in concanavalin A stimulated rat lymph node cells by serum from arthritic rats. Cellular and Molecular Life Sciences. 33(3). 390–391. 2 indexed citations
20.
Arrigoni‐Martelli, E., E. Bramm, E.C. HUSKISSON, D. A. Willoughby, & Paul Dieppe. (1976). Pertussis vaccine oedema: An experimental model for the action of penicillamine-like drugs. Inflammation Research. 6(5). 613–617. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026